More than 20 researchers at the University of Tennessee Health Science Center were recognized today for their work in both developing and commercializing discoveries that have the potential to transform the lives of people in Tennessee and throughout the world. At today’s annual Innovation Awards ceremony, hosted by the University of Tennessee Research Foundation (UTRF) (read more)
UTHSC
AutoZone Founder Pitt Hyde Offers Guidance To Aspiring Biotech Entrepreneurs
Whether you’re selling car parts or developing a drug, J.R. “Pitt” Hyde said the business idea is way less important than how you implement it. And Hyde should know. The AutoZone Inc. founder started the auto parts giant with four stores, and it now has more than 4,800. Now, as board chairman of Memphis-based drug (read more)
UTHSC Joins Lilly’s PD2 Program
The University of Tennessee Health Science Center is pleased to announce its membership in Eli Lilly’s Phenotypic Drug Discovery Program (“PD2 program”). Through this program, Lilly will evaluate new compounds developed at UTHSC for novelty as well as potential candidates for new drugs to bring to market. As a member of this program, all UTHSC (read more)